Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly ...

Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...

South Africa's Competition Commission is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

FDA approves insulin-aspart-szjj as biosimilar for diabetes treatment On February 14, 2025, Sanofi-Aventis announced the FDA approval ... aspart (Novolog), the approval includes both pre-filled pens ...

Merilog 100units/mL is supplied as both a 10mL multi-dose vial as well as a 3mL single-patient-use prefilled pen. The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a ...

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...

Insulin resistance in the brain is associated with obesity, type 2 diabetes, and cognitive dysfunction. Insulin normally regulates appetite and metabolism through brain signaling, but resistance ...